|
KMID : 1034820070030030195
|
|
Molecular & Cellular Toxicology
2007 Volume.3 No. 3 p.195 ~ p.197
|
|
|
The Effect of CYP Polymorphism on Resistance against Praziquantel in Clonorchis Sinensis-infected Patients
|
|
Kim Chung-Hyeon
Choi Min-Ho
Chai Jong-Yil
Shin Eun-Hee
Hong Sung-Tae
|
|
|
Abstract
|
|
|
|
Currently praziquantel is used for treatment of not only clonorchiasis but also other trematodes and cestodes. But cure rate of praziquantel is just 60-80% for most trematodes. It needs for the treatment-failed patients to have more drugs. The cause of failure of treatment is not studied. We just know that the blood level of praziquantel is severely different among the people. We guess that this factor may influence the results of treatment. In an endemic area of human clonorchiasis in Heilongjiang Providence, China, 78 subjects were selected for the study. Three doses of 25 mg/kg (total 75 mg/kg) of praziquantel were administered to 78 clonorchiasis patients. After three weeks of treatment, stool examination was undertaken once again to confirm the cured and uncured subjects. To analyze SNP (single nucleotide polymorphism) of CYP3A5 PS2-1, CYP3A5 PS2-2, and CYP3A5*6, PCR method was done with specifically designed primers. The mutation rates of all sites were not significant statistically. The number of subjects was too small, so we need more subjects and other delivery proteins of bile ducts (ex. MRP etc.) were also considered for effects of praziquantel. We analyzed, for the first time, the entire CYP3A5 gene in a French population, using a polymerase chain reaction- single strand conformational polymorphism (PCR-SSCP) strategy.
|
|
|
KEYWORD
|
|
|
Praziquantel, Clonorchis sinensis, SNP, CYP
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|